Metraipolis › archive › dc_82f09daa97d4

Antimycobacterial and immunomodulatory activities of sorafenib in a preclinical mouse model of TB infection through CD4+CD25low and CD8+CD25low effector T cells — Europe PMC PMID:40771802

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40771802
DOI
10.3389/fimmu.2025.1591026
License (as archived)
solo-consultazione
Archived
2026-10-07T20:29:20.351Z
SHA-256 of the archived text
0b96c05274f2e11855d84b22ade040c9bc1a069020382c69b7bcb84b5b45e898
Stable URL of this page
https://metraipolis.com/documento/dc_82f09daa97d4

How to cite

Antimycobacterial and immunomodulatory activities of sorafenib in a preclinical mouse model of TB infection through CD4+CD25low and CD8+CD25low effector T cells — Europe PMC PMID:40771802 — Europe PMC (en), https://europepmc.org/article/MED/40771802 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_82f09daa97d4 (Metraipolis archive dc_82f09daa97d4, sha256 0b96c05274f2e11855d84b22ade040c9bc1a069020382c69b7bcb84b5b45e898)
BibTeX
@misc{dc82f09daa97d4,
  title = {Antimycobacterial and immunomodulatory activities of sorafenib in a preclinical mouse model of TB infection through CD4+CD25low and CD8+CD25low effector T cells — Europe PMC PMID:40771802},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40771802},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_82f09daa97d4; sha256 0b96c05274f2e11855d84b22ade040c9bc1a069020382c69b7bcb84b5b45e898},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40771802. Agents can read the archived copy with the MCP tool read_document.